PTPN1 and type 2 diabetes mellitus: Protein tyrosine phosphatase 1B (PTP1B) plays a crucial role in negatively regulating insulin and leptin signaling pathways, making PTP1B inhibitors potential novel therapeutics for type 2 diabetes and obesity.